Search - Archive ouverte HAL Access content directly

Filter your results

49 Results
authFullName_s : Emmanuel Bachy

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

Philipp Staber , Marco Herling , Mar Bellido , Eric Jacobsen , Matthew Davids , et al.
Blood, 2019, 134 (14), pp.1132-1143. ⟨10.1182/blood.2019000402⟩
Journal articles hal-02318820v1
Image document

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

Sylvain Carras , Dimitri Chartoire , Sylvain Mareschal , Maël Heiblig , Antoine Marçais , et al.
The Journal of clinical investigation, 2021, 131 (13), pp.e139675. ⟨10.1172/jci139675⟩
Journal articles inserm-03280949v1

Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/ T‐Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire ( SFGM‐TC )

Laure Philippe Walter , Lucile Couronné , Jean‐philippe Jais , Phong‐dinh Nguyen , Didier Blaise , et al.
American Journal of Hematology, 2021, 96 (7), pp.834-845. ⟨10.1002/ajh.26200⟩
Journal articles hal-03623641v1

Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?

Pierre Sujobert , Gilles Salles , Emmanuel Bachy
Hematology/Oncology Clinics of North America, 2016, 30 (6), pp.1163-1177. ⟨10.1016/j.hoc.2016.07.001⟩
Journal articles hal-01800003v1

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Estelle Bourbon , Delphine Maucort-Boulch , Juliette Fontaine , Claire Mauduit , Pierre Sesques , et al.
Blood Advances, 2021, 5 (16), pp.3227-3239. ⟨10.1182/bloodadvances.2021004515⟩
Journal articles hal-04151083v1

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

Pierre Sesques , Jessie Bourcier , Camille Golfier , Laure Lebras , Emmanuelle Nicolas‐virelizier , et al.
Hematological Oncology, 2020, 38 (2), pp.137-145. ⟨10.1002/hon.2713⟩
Journal articles inserm-03496368v1

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients

Rafik Haderbache , Walid Warda , Eric Hervouet , Mathieu Neto da Rocha , Rim Trad , et al.
Journal of Translational Medicine, 2021, 19 (1), ⟨10.1186/s12967-021-02925-z⟩
Journal articles hal-03443941v1

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients: Platinum-containing chemotherapy regimens

F. Tixier , F. Ranchon , A. Iltis , N. Vantard , V. Schwiertz , et al.
Hematological Oncology, 2017, 35 (4), pp.584-590. ⟨10.1002/hon.2328⟩
Journal articles hal-01796180v1

Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival--A Study From the Groupe d'Etude des Lymphomes de l'Adulte.

Emmanuel Bachy , Pauline Brice , Richard Delarue , Nicole Brousse , Corinne Haioun , et al.
Journal of Clinical Oncology, 2009, epub ahead of print. ⟨10.1200/JCO.2009.22.7819⟩
Journal articles hal-00453229v1
Image document

L’émergence des traitements par cellules CAR-T dans les lymphomes

Gilles Salles , Pierre Sesques , Emmanuelle Ferrant , Violaine Safar , Hervé Ghesquieres , et al.
Bulletin du Cancer, 2018, 105, pp.S168 - S177. ⟨10.1016/S0007-4551(19)30047-5⟩
Journal articles hal-03486656v1

Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study

Guillaume Cartron , Emmanuel Bachy , Hervé Tilly , Nicolas Daguindau , Gian-Matteo Pica , et al.
Journal of Clinical Oncology, 2023, 41 (19), pp.3523-3533. ⟨10.1200/JCO.22.02327⟩
Journal articles hal-04212199v1

Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

François Lemonnier , Violaine Safar , Asma Beldi-Ferchiou , Anne-Ségolène Cottereau , Emmanuel Bachy , et al.
Blood Advances, 2021, 5 (2), pp.539-548. ⟨10.1182/bloodadvances.2020003081⟩
Journal articles hal-03226483v1
Image document

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Roberta Di Blasi , Steven Le Gouill , Emmanuel Bachy , Guillaume Cartron , David Beauvais , et al.
Blood, 2022, 140 (24), pp.2584-2593. ⟨10.1182/blood.2022016945⟩
Journal articles hal-03903472v1

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

Clémentine Sarkozy , Sophie Kaltenbach , Pierre Faurie , Danielle Canioni , Françoise Berger , et al.
Genes, Chromosomes & Cancer, 2017, 56, pp.221-230. ⟨10.1002/gcc.22428⟩
Journal articles hal-01795702v1
Image document

Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC

David Beauvais , Emmanuel Bachy , André Baruchel , Jacques-Olivier Bay , Denis Caillot , et al.
Bulletin du Cancer, 2021, 108 (7-8), pp.725-729. ⟨10.1016/j.bulcan.2020.10.017⟩
Journal articles inserm-03349011v1
Image document

Controversies in the Treatment of Peripheral T-cell Lymphoma

Emmanuel Bachy , Alessandro Broccoli , Claire Dearden , Laurence de Leval , Philippe Gaulard , et al.
HemaSphere, 2020, HemaSphere, 4 (5), pp.e461. ⟨10.1097/HS9.0000000000000461⟩
Journal articles hal-04215545v1

Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival

Jean-Emmanuel Serre , David Michonneau , Emmanuel Bachy , Laure-Hélène Noël , Valérie Dubois , et al.
Kidney International, 2014, 85 (1), pp.182-190. ⟨10.1038/ki.2013.253⟩
Journal articles hal-01911491v1

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Emilie Reboursiere , Fabien Le Bras , Charles Herbaux , Emmanuel Gyan , Aline Clavert , et al.
Oncotarget, 2016, 7 (51), pp.85573-85583. ⟨10.18632/oncotarget.10764⟩
Journal articles hal-01475957v1

CD1d-restricted peripheral T cell lymphoma in mice and humans

Emmanuel Bachy , Mirjam Urb , Shilpi Chandra , Rémy Robinot , Gabriel Bricard , et al.
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
Journal articles hal-01305487v1

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

Alexandre Morel , Josette Brière , Laurence Lamant , Michael Loschi , Corinne Haioun , et al.
European Journal of Cancer, 2017, 83, pp.146 - 153. ⟨10.1016/j.ejca.2017.06.026⟩
Journal articles hal-01655967v1
Image document

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study

Emmanuel Bachy , Jane A. Estell , Eric van De Neste , Reda Bouabdallah , Joan Bargay , et al.
American Journal of Hematology, 2016, 91 (4), pp.410-415. ⟨10.1002/ajh.24305⟩
Journal articles hal-01263105v1

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients

Pierre Walczak , Sylvain Choquet , Jacques Dantal , David Boutboul , Felipe Suarez , et al.
Journal articles hal-04212687v1

Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial

Roch Houot , Emmanuel Bachy , Guillaume Cartron , François-Xavier Gros , Franck Morschhauser , et al.
Nature Medicine, 2023, ⟨10.1038/s41591-023-02572-5⟩
Journal articles hal-04212634v1
Image document

B-cell malignancies and COVID-19: a narrative review

David Luque-Paz , Pierre Sesques , Florent Wallet , Emmanuel Bachy , Florence Ader
Clinical Microbiology and Infection, 2023, ⟨10.1016/j.cmi.2022.10.030⟩
Journal articles hal-03955801v1

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

Irit Avivi , Luca Arcaini , Virginia Ferretti , Ariane Boumendil , Hervé Finel , et al.
British Journal of Haematology, 2018, 182 (6), pp.807-815. ⟨10.1111/bjh.15454⟩
Journal articles hal-01841287v1

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes

Lauriane Filliatre-Clement , Delphine Maucort-Boulch , Estelle Bourbon , Lionel Karlin , Violaine Safar , et al.
Hematological Oncology, 2018, 36 (3), pp.533-542. ⟨10.1002/hon.2512⟩
Journal articles hal-04151954v1

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program

Bastien Collomb , Amélie Dubromel , Anne Gaëlle Caffin , Chloé Herledan , Virginie Larbre , et al.
Cancers, 2022, 14 (3), pp.660. ⟨10.3390/cancers14030660⟩
Journal articles hal-04150994v1
Image document

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Estelle Bourbon , Pierre Sesques , Morgane Gossez , Jérémie Tordo , Emmanuelle Ferrant , et al.
Blood Advances, 2023, 7 (5), pp.744-755. ⟨10.1182/bloodadvances.2021006563⟩
Journal articles inserm-04028897v1
Image document

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients

Mathilde Lamarque , Céline Bossard , Adrien Contejean , Pauline Brice , Marie Parrens , et al.
Haematologica, 2016, 101 (3), Epub 2015 Dec 24. ⟨10.3324/haematol.2015.135400⟩
Journal articles inserm-01419525v1

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

Adèle de Masson , Marie Beylot-Barry , Caroline Ram-Wolff , Jean-Baptiste Mear , Stéphane Dalle , et al.
The Lancet, 2023, 401 (10392), pp.1941-1950. ⟨10.1016/S0140-6736(23)00329-X⟩
Journal articles hal-04209846v1